Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of EvroTrans recommended that dividends be paid for 3 months 2024

5/27/24 EUTR

Board of Directors of EvroTrans recommended that dividends be paid for 2023

5/27/24 EUTR

Board of Directors of INARCTICA recommended that dividends be paid for 3 months 2024

5/27/24 AQUA

Shareholders of TGC-14 approved dividends for 2023

5/27/24 TGKN

Rosseti Kuban reported for 3 months of 2024 by IFRS

5/27/24 KUBE

Rosseti Volga reported for 3 months of 2024 by IFRS

5/27/24 MRKV

Board of Directors of Kamaz recommended that dividends be paid for 2023

5/27/24 KMAZ

Board of Directors of Rosneft-Smolensknefteprodukt recommended that dividends be paid for 2023

5/27/24 SMNF

Novatek to build a cargo terminal in the port of Sabetta

5/27/24 NVTK

Board of Directors of Astra recommended that dividends be paid for 3 months 2024

5/27/24 ASTR